Advertisement

Topics

MorphoSys AG, Company Profile

18:37 EST 15th December 2018 | BioPortfolio

MorphoSys AG, located in Martinsried/Munich, is one of the world's leading biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next generation of antibodies, which can be used to treat diseases and for research and diagnostics purposes. Numerous partnerships have already been entered into with well-known companies from the pharmaceutical and biotechnology sectors, such as Bayer, Boehringer Ingelheim, Centocor/Johnson & Johnson, Daiichi Sankyo, Novartis, Pfizer, Roche and Schering.The Company, founded in 1992, possesses the unique HuCAL technology (the Human Combinatorial Antibody Library). This library comprises more than ten billion different, fully human antibodies. HuCAL is a very powerful technology, which allows rapid and automated production of high-affinity antibodies. The most important feature of the library is its capability of optimizing fully human antibodies to meet predefined specifications.

Location

Lena-Christ-Strasse 48
Martinsried
Planegg
82152
Germany

Contact

Phone: 49 (0)89 / 899 27-0
Fax: 49 (0)89 / 899 27-222
Email: investors@morphosys.com


News Articles [421 Associated News Articles listed on BioPortfolio]

MorphoSys AG: Ad hoc: MorphoSys and Galapagos Sign Global License Agreement for MOR106 with Novartis and MorphoSys Increases its Financial Guidance for 2018

PLANEGG/MUNICH, GERMANY and MECHELEN, BELGIUM / ACCESSWIRE / July 19, 2018 / MorphoSys AG (NASDAQ: MOR), (FSE: MOR), (XETRA: MOR) announces today that MorphoSys and Galapagos NV have entered into a...

MorphoSys AG: MorphoSys and I-Mab Sign Strategic Partnering Agreement for MorphoSys's Novel Immuno-Oncology Agent MOR210

PLANEGG/MUNICH, GERMANY / ACCESSWIRE / November 15, 2018 / MorphoSys AG (FSE: MOR; Prime Standard Segment, MDAX & TecDAX; NASDAQ: MOR) and I-Mab Biopharma ("I-Mab"), a biotech company focusing excl...

Morphosys: Positive Faktoren

Die Analysten von Independent Research bestätigen die Halteempfehlung für die Aktien von Morphosys. Das Kursziel für die Papiere von Morphosys sehen die Experten weiter bei 120,00 Euro. Die Zahlen ...

Morphosys: Größere Zuversicht

Amerikanische Experten äußern sich lobend zu Morphosys. Die Analysten von JP Morgan bestätigen in einer aktuellen Studie das Rating "overweight" für die Papiere von Morphosys. Das Kursziel für di...

MorphoSys: Gutes von Guselkumab

Der Medikamentenwirkstoff MorphoSys sorgt weiter für gute Nachrichten von MorphoSys. Das Biotechunternehmen meldet die Zulassung des Wirkstoffs in Japan. Damit kann die japanische Tochtergesellscha.....

Morphosys: Ein Plus von 6 Euro

Neue Daten aus der Forschung fließen in das Modell von Oddo BHF zu Morphosys ein. Wie bisher sprechen die Experten eine Kaufempfehlung für die Aktien von Morphosys aus. Geändert wird jedoch das Kur...

Morphosys: Prognose wird angepasst

Die Analysten von Independent Research bestätigen die Halteempfehlung für die Aktien von Morphosys. Das Kursziel für die Papiere von Morphosys sahen die Experten bisher bei 110,00 Euro. In der heut...

Morphosys: Pessimismus trotz guter Daten

Die Analysten von RBC bestätigen ihre Einschätzung zur Aktie von Morphosys. Demnach steht das Rating für die Papiere von Morphosys weiter auf "underperform". Das Kursziel für die Aktien von Morpho...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [5 Associated Companies listed on BioPortfolio]

MorphoSys GmbH

MorphoSys AG, located in Martinsried/Munich, is one of the world's leading biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next ge...

Biogenesis Ltd

Biogenesis is a recognized leader in the supply of monoclonal and polyclonal antibodies and custom manufacturing services to IVD manufacturers, pharmaceutical companies and life science researchers ar...

MorphoSys AG,

MorphoSys AG, located in Martinsried/Munich, is one of the world's leading biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next ge...

MorphoSys AG

MorphoSys AG, located in Martinsried/Munich, is one of the world's leading biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next ge...

Antibodies by Design

Antibodies by Design uses proven MorphoSys recombinant antibody technology to provide high quality monoclonal antibodies to its customers in record time. The HuCAL GOLD® library contains over 15 bill...

More Information about "MorphoSys AG," on BioPortfolio

We have published hundreds of MorphoSys AG, news stories on BioPortfolio along with dozens of MorphoSys AG, Clinical Trials and PubMed Articles about MorphoSys AG, for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MorphoSys AG, Companies in our database. You can also find out about relevant MorphoSys AG, Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record